Somaiya Mayur Ian

Chief Financial Officer at NAMS; Chief Financial Officer at TCR2 THERAPEUTICS INC.

Sold, on record
$3.6M
Dollars the filings state
Form 4 sales
5
Latest Jan 21, 2026
Form 144 notices
3
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale TCR2 THERAPEUTICS INC.Unusual
    Nov 17, 2020 2020

    Sold 3,666 shares at $30.00 ($110k)

    Somaiya Mayur Ian, Chief Financial Officer

    Sold 71.3% of holdings ($154k position)1,473 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale TCR2 THERAPEUTICS INC.Unusual
    Dec 14, 2020 +27 days

    Sold 2,000 shares at $35.00 ($70k)

    Somaiya Mayur Ian, Chief Financial Officer

    Sold 57.6% of holdings ($122k position)1,473 shares leftFiling

  3. 3 Form 144 notice NAMSNotice
    Jan 27, 2025 +1505 days

    Filed to sell 200,000 shares ($4.6M)

    Somaiya Mayur Ian, Affiliate

    10b5-1 planFirst sale on recordFiling

  4. 4 Form 4 sale NAMSRoutine
    Jan 28, 2025 +1 day

    Sold 61,883 shares

    Somaiya Mayur Ian, Chief Financial Officer

    10b5-1 planSold 62% of holdings38,000 shares leftFirst sale on recordFollows a Form 144Filing

  5. 5 Form 144 notice NAMSNotice
    Jan 5, 2026 +342 days

    Filed to sell 5,118 shares ($170k)

    Somaiya Mayur Ian, affiliate

    No 10b5-1 planFiling

  6. 6 Form 4 sale NAMSRoutine
    Jan 5, 2026 same day

    Sold 5,118 shares at $33.25 ($170k)

    Somaiya Mayur Ian, Chief Financial Officer

    10b5-1 planSold 13.5% of holdings ($1.3M position)32,882 shares leftFollows a Form 144Filing

  7. 7 Form 144 notice NAMSNotice
    Jan 20, 2026 +15 days

    Filed to sell 200,000 shares ($6.3M)

    Somaiya Mayur Ian, Affiliate

    10b5-1 planFiling

  8. 8 Form 4 sale NAMSRoutine
    Jan 21, 2026 +1 day

    Sold 100,000 shares at $32.61 ($3.3M)

    Somaiya Mayur Ian, Chief Financial Officer

    10b5-1 planSold 63.1% of holdings ($5.2M position)58,382 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Somaiya Mayur Ian
Source
Jan 21, 2026Jan 22, 2026NAMSChief Financial OfficerForm 4 sale100,000$3.3M63.1%RoutineSEC
Jan 20, 2026Jan 20, 2026NAMSAffiliateForm 144 notice200,000$6.3MNoticeSEC
Jan 5, 2026Jan 7, 2026NAMSChief Financial OfficerForm 4 sale5,118$170k13.5%RoutineSEC
Jan 5, 2026Jan 5, 2026NAMSaffiliateForm 144 notice5,118$170kNoticeSEC
Jan 28, 2025Jan 29, 2025NAMSChief Financial OfficerForm 4 sale61,88362.0%RoutineSEC
Jan 27, 2025Jan 27, 2025NAMSAffiliateForm 144 notice200,000$4.6MNoticeSEC
Dec 14, 2020Dec 16, 2020TCR2 THERAPEUTICS INC.Chief Financial OfficerForm 4 sale2,000$70k57.6%UnusualSEC
Nov 17, 2020Nov 19, 2020TCR2 THERAPEUTICS INC.Chief Financial OfficerForm 4 sale3,666$110k71.3%UnusualSEC